Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Metabolic conditions People with diabetes or prediabetes can note that AOD 9604 does not impair glucose metabolism
Key Features D-retro-inverso peptide model for in vitro research Suitable for studies involving FOXO-associated proteinprotein interactions Used in controlled investigations of senescence-related cellular pathways Supplied as a lyophilised powder for convenient handling and storage 10 mg per vial Released only after internal quality control review Specifications for FOXO4-DRI Product name: FOXO4-DRI Also known as: FOXO4 DRI, FOXO4 peptide (D-retro-inverso), FOX04, FOX04-DRI Class: Peptide analogue (research use) Form: Lyophilised powder Unit size: 10 mg Appearance: White to off-white solid Lot note: Counter-ion content and hydration state may vary between batches
Hold the vial upright when drawing so the needle tip is submerged below any surface bubbles
Learn more in the update to our B Vitamins and Energy Drinks Review
Dose-Response Relationships In animal stroke models, gene expression changes occurred 1-24 hours post-administration, but whether similar timing applies to psychiatric effects is unknown
US$ 26.45
US$ 24.16
US$ 21.00
US$ 26.84
US$ 23.83
US$ 22.52
